IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
LEARN MORE
IJPC on Facebook
 
Sign On
  • Home
  • About
    • The Journal
    • Editor-In-Chief
    • Editorial Calendar
    • Submissions
    • Advertising
    • Permissions & Reprints
    • Privacy Policy
  • Subscriptions
    • Subscribe
    • Renew
    • Prices
    • Free Sample
  • Store
    • View Shopping Cart
    • Back Issues
    • Articles
    • Library Archives
    • Compounding Theme Archives
    • Other Products
  • Resources
    • Supplemental Content and Errata
    • Training and Education
    • IJPC-PCAB SOP Matrix
    • USP GAP Analysis
    • Compounders' Network List
    • Patient Information
    • Videos
    • Compounders' Resource Directory
  • Account
  • Contact US

Library CD
Volume 20, 2016 CD
Six back issues from 2016 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.
Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 20 No. 1 January/February 2016 Volume 20, Number 1
Vol. 20 No. 2 March/April 2016 Volume 20, Number 2
Vol. 20 No. 3 May/June 2016 Volume 20, Number 3
Vol. 20 No. 4 July/August 2016 Volume 20, Number 4
Vol. 20 No. 5 September/October 2016 Volume 20, Number 5
Vol. 20 No. 6 November/December 2016 Volume 20, Number 6

Volume 20, 2016 CD ARTICLES

Volume 20, 2016 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: Starting Year 20! Vol. 20 No. 1 4
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Vol. 20 No. 1 6
Microbial Identification in Pharmaceutical Compounding Vol. 20 No. 1 13
Basic Principles of Lyophilization, Part 2 Vol. 20 No. 1 20
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Vol. 20 No. 1 29
Formulation and Stability of Solutions Vol. 20 No. 1 41
Calculations Vol. 20 No. 1 46
Aprepitant 80-mg Capsules Vol. 20 No. 1 48
Aripiprazole 10-mg Oral Dissolving Tablets Vol. 20 No. 1 49
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Vol. 20 No. 1 50
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Vol. 20 No. 1 51
Mupirocin Calcium 2% Cream Vol. 20 No. 1 52
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Vol. 20 No. 1 53
Thrombin 1,000 Units/mL Topical Solution, Sterile Vol. 20 No. 1 54
Tropicamide 1% Ophthalmic Solution Vol. 20 No. 1 55
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Vol. 20 No. 1 56
Voriconazole 10-mg/mL Ophthalmic Solution Vol. 20 No. 1 57
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Vol. 20 No. 1 58
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation Vol. 20 No. 1 63
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Vol. 20 No. 1 71
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Vol. 20 No. 1 81
PostScription: The Home Field Advantage Vol. 20 No. 1 86
PreScription: Compounding: A Changing Paradigm Vol. 20 No. 2 92
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Vol. 20 No. 2 95
Root Cause Analysis, Part 2: Sterile Compounding Vol. 20 No. 2 99
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Vol. 20 No. 2 107
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Vol. 20 No. 2 114
Basics of Compounding: Capsules Vol. 20 No. 2 125
Formulation and Stability of Solutions Vol. 20 No. 2 137
Calculations Vol. 20 No. 2 142
Blue Goo Anti-Itch Gel Vol. 20 No. 2 144
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Vol. 20 No. 2 145
Medicated Polyox Bandage for Skin Ulcers Vol. 20 No. 2 146
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Vol. 20 No. 2 147
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Vol. 20 No. 2 148
Utilization of Compounded Medications in an Oral Medicine Practice Vol. 20 No. 2 155
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Vol. 20 No. 2 159
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Vol. 20 No. 2 164
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 2 167
PreScription: Patient Access to Pharmaceuticals Vol. 20 No. 3 180
Current Perspectives on the Syringe Delivery System Vol. 20 No. 3 182
Compounding in Nigeria Vol. 20 No. 3 189
IACP Names Voliva Executive Vice President Vol. 20 No. 3 194
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Vol. 20 No. 3 197
Does Your Drug Expertise Include Clinical Pharmaceutics? Vol. 20 No. 3 202
Basics of Compounding: Special Capsules Vol. 20 No. 3 209
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Vol. 20 No. 3 217
Calculations Vol. 20 No. 3 224
Carboplatin 50-mg/mL Injection Vol. 20 No. 3 226
Cefotetan Disodium Injection Vol. 20 No. 3 227
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Vol. 20 No. 3 228
Dexpanthenol 5% Nasal Spray Vol. 20 No. 3 229
Indomethacin Gel Vol. 20 No. 3 230
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Vol. 20 No. 3 231
Montelukast Sodium 5-mg Fast-Dissolving Film Vol. 20 No. 3 232
Pain-Away II Headache Capsules Vol. 20 No. 3 233
Sodium Nitroprusside 25-mg/mL Injection Vol. 20 No. 3 234
Zolpidem Tartrate 5-mg and 10-mg Capsules Vol. 20 No. 3 235
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Vol. 20 No. 3 236
Topical Metered-dosing Dispenser Performance Evaluation Vol. 20 No. 3 239
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Vol. 20 No. 3 247
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Vol. 20 No. 3 250
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Vol. 20 No. 3 257
PostScription: Supporting Your Alma Mater: Whose World Will You Change? Vol. 20 No. 3 262
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Vol. 20 No. 4 268
Compounding Transdermal Medication for Feline Patients Vol. 20 No. 4 271
Case Report: Pediatric Scar Management After Open-heart Surgery Vol. 20 No. 4 277
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Vol. 20 No. 4 283
IACP's 2016 Compounders on Capitol Hill Asks Vol. 20 No. 4 294
Basics of Compounding: Compounding Films Vol. 20 No. 4 298
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Vol. 20 No. 4 307
Calculations Vol. 20 No. 4 316
Dolasetron Mesylate 20-mg/mL Injection Vol. 20 No. 4 318
Gatifloxacin 0.5% Ophthalmic Solution Vol. 20 No. 4 319
Mebendazole 100-mg Capsules Vol. 20 No. 4 320
Neomycin Sulfate 25-mg/mL Oral Solution Vol. 20 No. 4 321
Nystatin 100,000-units Vaginal Inserts Vol. 20 No. 4 322
1,2-Octanediol 5% Topical Liquid Vol. 20 No. 4 323
Phytonadione 1-mg/mL Oral Solution Vol. 20 No. 4 324
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Vol. 20 No. 4 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Vol. 20 No. 4 326
Tretinoin 10-mg Oral Capsules Vol. 20 No. 4 327
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Vol. 20 No. 4 328
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Vol. 20 No. 4 333
Stability of Ampicillin in Normal Saline and Buffered Normal Saline Vol. 20 No. 4 338
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Vol. 20 No. 4 343
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Vol. 20 No. 4 347
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Vol. 20 No. 4 351
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Vol. 20 No. 5 356
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Vol. 20 No. 5 359
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Vol. 20 No. 5 367
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Vol. 20 No. 5 377
Quality Control Analytical Methods: Method Validation Vol. 20 No. 5 381
Basics of Compounding: Clinical Pharmaceutics, Part 1 Vol. 20 No. 5 389
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Vol. 20 No. 5 399
Calculations Vol. 20 No. 5 405
Clobazam 1-mg/mL Oral Suspension Vol. 20 No. 5 406
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Vol. 20 No. 5 407
Inamrinone 5-mg/mL Injection Vol. 20 No. 5 408
Levetiracetam 50-mg/mL Oral Suspension Vol. 20 No. 5 409
Naproxen 5% Cream Vol. 20 No. 5 410
Permethrin 1% Lotion Vol. 20 No. 5 411
Progesterone 10% Cream Vol. 20 No. 5 412
Sodium Phosphate Oral Solution Vol. 20 No. 5 413
Tetracaine Hydrochloride 2% Topical Solution Vol. 20 No. 5 414
Tromethamine Injection Vol. 20 No. 5 415
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Vol. 20 No. 5 416
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Vol. 20 No. 5 421
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 5 426
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Vol. 20 No. 5 435
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Vol. 20 No. 5 438
PreScription: Two Decades of IJPC Vol. 20 No. 6 444
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Vol. 20 No. 6 447
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Vol. 20 No. 6 457
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Vol. 20 No. 6 461
Why Become Pharmacy Compounding Accreditation Board Accredited? Vol. 20 No. 6 469
The "Lists": What Do They Mean? Vol. 20 No. 6 477
Introduction to Quality Control in a Compounding Pharmacy Vol. 20 No. 6 481
Basics of Compounding: Clinical Pharmaceutics, Part 2 Vol. 20 No. 6 485
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Vol. 20 No. 6 495
Calculations Vol. 20 No. 6 502
Alendronate 70-mg/75-mL Drinkable Formulation Vol. 20 No. 6 504
Bosentan 6.25-mg/mL Oral Suspension Vol. 20 No. 6 505
Capsaicin 0.025% and Doxepin 3.3% Cream Vol. 20 No. 6 506
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Vol. 20 No. 6 507
Erlotinib 10-mg/mL Oral Suspension Vol. 20 No. 6 508
Flumazenil 0.1-mg/mL Injection Vol. 20 No. 6 509
Imatinib 40-mg/mL Oral Suspension Vol. 20 No. 6 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension Vol. 20 No. 6 511
Melatonin 2-mg/mL Oral Suspension Vol. 20 No. 6 512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Vol. 20 No. 6 513
Stability of Fentanyl Citrate in Polyolefin Bags Vol. 20 No. 6 514
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Vol. 20 No. 6 517
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Vol. 20 No. 6 521
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Vol. 20 No. 6 526
Home |  About  |  Contact  |  Advertising |  Privacy Policy                                                            ©2019 IJPC, Inc.